How to Record Med-Tech M&A Earn-outs
Recording the initial liability and subsequent fair value adjustments for contingent consideration tied to FDA approval milestones or revenue targets following an acquisition.
| Account Name | Type | Debit ($) | Credit ($) |
|---|---|---|---|
| Goodwill | Asset | 500,000.00 | - |
| Contingent Consideration Liability | Liability | - | 500,000.00 |
💡 Accountant's Note
At the acquisition date, the fair value of the earn-out must be recognized as part of the purchase price. Changes in the estimated probability of achieving FDA clearance require adjusting the liability through the income statement in subsequent periods.
Practitioner & Systems Framework
💻 ERP Architecture
Tracked in the Long-Term Liability module with monthly fair value revaluation entries.
⚠️ Audit Flags
Adjustments to the liability coincide with clinical trial results or FDA communication logs.
📄 Required Documentation
Purchase Agreement, third-party valuation report of the earn-out, and regulatory milestone status reports.
Automate this entry with the JEH Accounting Suite
Stop doing manual entry. Our VBA-powered ERP automatically generates your ledgers, Trial Balance, and Financial Statements.
No Subscriptions. Own your data.
Expert Analysis by Qusai Ahmad
General Accountant Supervisor & IFRS Specialist
Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.
Related Journal Entries
Discussion & Community Questions
Loading comments...